Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
Tenet Healthcare (THC) ended the recent trading session at $200.48, demonstrating a -2.12% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.58% for the day. Shares of the hospital operator have appreciated by 4.3% over the course of the past month, outperforming the Medical sector's gain of 2.74%, and the S&P 500's gain of 3.68%.The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. The company is slated to reveal its earnings on October 28, 2025. In that report, analysts expect Tenet Healthcare to post earnings of $3.35 per share. This would mark year-over-year growth of 14.33%. Our most recent consensus estimate is calling for quarterly revenue of $5.25 billion, up 2.42% from the year-ago period. For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $15.85 per share and a revenue of $21.15 billion, representing changes of +33.42% and +2.36%, respectively, from the prior year. Investors might also notice recent changes to analyst estimates for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, there's been a 0.01% fall in the Zacks Consensus EPS estimate. At present, Tenet Healthcare boasts a Zacks Rank of #4 (Sell). In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 12.93. This denotes a premium relative to the industry average Forward P/E of 11.86. Investors should also note that THC has a PEG ratio of 0.88 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical - Hospital industry currently had an average PEG ratio of 1.13 as of yesterday's close. The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 204, this industry ranks in the bottom 18% of all industries, numbering over 250. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Quelle: Zacks
Nachrichten zu Tenet Healthcare Corp.
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Tenet Healthcare Corp.
Datum | Rating | Analyst | |
---|---|---|---|
26.11.2012 | Tenet Healthcare neutral | Robert W. Baird & Co. Incorporated | |
25.09.2012 | Tenet Healthcare neutral | UBS AG | |
17.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
10.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
02.04.2012 | Tenet Healthcare overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
17.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
10.05.2012 | Tenet Healthcare overweight | Barclays Capital | |
02.04.2012 | Tenet Healthcare overweight | Barclays Capital | |
03.11.2011 | Tenet Healthcare overweight | Barclays Capital | |
04.08.2011 | Tenet Healthcare overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
26.11.2012 | Tenet Healthcare neutral | Robert W. Baird & Co. Incorporated | |
25.09.2012 | Tenet Healthcare neutral | UBS AG | |
03.11.2011 | Tenet Healthcare sector perform | RBC Capital Markets | |
21.07.2010 | Tenet Healthcare neutral | UBS AG | |
02.06.2010 | Tenet Healthcare Downgrade | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
28.01.2009 | Tenet Healthcare underperform | RBC Capital Markets | |
01.10.2008 | Tenet Healthcare Downgrade | UBS AG | |
08.11.2007 | Tenet Healthcare underweight | Lehman Brothers Inc. | |
08.11.2007 | Tenet Healthcare underperform | Cowen and Company, LLC | |
11.09.2007 | Tenet Healthcare underweight | Lehman Brothers Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen